242 related articles for article (PubMed ID: 2188774)
21. Opioid rotation from oral morphine to oral oxycodone in cancer patients with intolerable adverse effects: an open-label trial.
Narabayashi M; Saijo Y; Takenoshita S; Chida M; Shimoyama N; Miura T; Tani K; Nishimura K; Onozawa Y; Hosokawa T; Kamoto T; Tsushima T;
Jpn J Clin Oncol; 2008 Apr; 38(4):296-304. PubMed ID: 18326541
[TBL] [Abstract][Full Text] [Related]
22. Tolerability and efficacy of two synergistic ratios of oral morphine and oxycodone combinations versus morphine in patients with chronic noncancer pain.
de la Iglesia FA; Pace GW; Robinson GL; Huang NY; Stern W; Richards P
J Opioid Manag; 2012; 8(2):89-98. PubMed ID: 22616314
[TBL] [Abstract][Full Text] [Related]
23. Morphine or oxycodone in cancer pain?
Heiskanen TE; Ruismäki PM; Seppälä TA; Kalso EA
Acta Oncol; 2000; 39(8):941-7. PubMed ID: 11207001
[TBL] [Abstract][Full Text] [Related]
24. A comparison of intravenous oxycodone and intravenous morphine in patient-controlled postoperative analgesia after laparoscopic hysterectomy.
Lenz H; Sandvik L; Qvigstad E; Bjerkelund CE; Raeder J
Anesth Analg; 2009 Oct; 109(4):1279-83. PubMed ID: 19762758
[TBL] [Abstract][Full Text] [Related]
25. A randomized double-blind crossover comparison of continuous and intermittent subcutaneous administration of opioid for cancer pain.
Watanabe S; Pereira J; Tarumi Y; Hanson J; Bruera E
J Palliat Med; 2008 May; 11(4):570-4. PubMed ID: 18454609
[TBL] [Abstract][Full Text] [Related]
26. Morphine or oxycodone for cancer-related pain? A randomized, open-label, controlled trial.
Riley J; Branford R; Droney J; Gretton S; Sato H; Kennett A; Oyebode C; Thick M; Wells A; Williams J; Welsh K; Ross J
J Pain Symptom Manage; 2015 Feb; 49(2):161-72. PubMed ID: 24975432
[TBL] [Abstract][Full Text] [Related]
27. Oral versus intravenous opioid dosing for the initial treatment of acute musculoskeletal pain in the emergency department.
Miner JR; Moore J; Gray RO; Skinner L; Biros MH
Acad Emerg Med; 2008 Dec; 15(12):1234-40. PubMed ID: 18945240
[TBL] [Abstract][Full Text] [Related]
28. A randomised comparison of regular oral oxycodone and intrathecal morphine for post-caesarean analgesia.
McDonnell NJ; Paech MJ; Browning RM; Nathan EA
Int J Obstet Anesth; 2010 Jan; 19(1):16-23. PubMed ID: 19700304
[TBL] [Abstract][Full Text] [Related]
29. Morphine versus oxycodone analgesia after percutaneous kidney stone surgery: a randomised double blinded study.
Pedersen KV; Olesen AE; Drewes AM; Osther PJ
Urolithiasis; 2013 Oct; 41(5):423-30. PubMed ID: 23828457
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of oxycodone/paracetamol for patients with bone-cancer pain: a multicenter, randomized, double-blinded, placebo-controlled trial.
Sima L; Fang WX; Wu XM; Li F
J Clin Pharm Ther; 2012 Feb; 37(1):27-31. PubMed ID: 21208247
[TBL] [Abstract][Full Text] [Related]
31. Single-dose and steady-state pharmacokinetics and pharmacodynamics of oxycodone in patients with cancer.
Leow KP; Smith MT; Williams B; Cramond T
Clin Pharmacol Ther; 1992 Nov; 52(5):487-95. PubMed ID: 1424423
[TBL] [Abstract][Full Text] [Related]
32. Oral oxycodone hydrochloride versus epidural anaesthesia for pain control after radical retropubic prostatectomy.
Hohwü L; Akre O; Bergenwald L; Törnblom M; Gustafsson O
Scand J Urol Nephrol; 2006; 40(3):192-7. PubMed ID: 16809258
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of rapid titration with intravenous administration of oxycodone injection in advanced cancer patients with severe pain.
Nakajima N
Jpn J Clin Oncol; 2019 Dec; 49(11):1061-1064. PubMed ID: 31612910
[TBL] [Abstract][Full Text] [Related]
34. A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients.
Nosek K; Leppert W; Nosek H; Wordliczek J; Onichimowski D
Drug Des Devel Ther; 2017; 11():2409-2419. PubMed ID: 28860712
[TBL] [Abstract][Full Text] [Related]
35. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
36. Therapy switching in patients receiving long-acting opioids.
Berger A; Hoffman DL; Goodman S; Delea TE; Seifeldin R; Oster G
Ann Pharmacother; 2004 Mar; 38(3):389-95. PubMed ID: 14742831
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of sustained-release oxycodone compared with immediate-release morphine for pain titration in cancer patients: A multicenter, open-label, randomized controlled trial (SOCIAL).
Pan H; Shen P; Shu Q; Lu L; Qian S; Zhou Y; Han F; Guo Q; Yang Z; Pan J; Xu Q; Zhang P; Wang K
Medicine (Baltimore); 2019 Jun; 98(24):e15505. PubMed ID: 31192908
[TBL] [Abstract][Full Text] [Related]
38. How to switch from morphine or oxycodone to methadone in cancer patients? a randomised clinical phase II trial.
Moksnes K; Dale O; Rosland JH; Paulsen O; Klepstad P; Kaasa S
Eur J Cancer; 2011 Nov; 47(16):2463-70. PubMed ID: 21775131
[TBL] [Abstract][Full Text] [Related]
39. Patient-controlled analgesia versus oral controlled-release oxycodone - are they interchangeable for acute postoperative pain after laparoscopic colorectal surgeries?
Ho HS
Oncology; 2008; 74 Suppl 1():61-5. PubMed ID: 18758200
[TBL] [Abstract][Full Text] [Related]
40. Morphine versus oxycodone in pancreatic cancer pain: a randomized controlled study.
Mercadante S; Tirelli W; David F; Arcara C; Fulfaro F; Casuccio A; Gebbia V
Clin J Pain; 2010; 26(9):794-7. PubMed ID: 20973155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
